BA
AGIO icon

BlackRock Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

BlackRock Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.45M Sell
202,518
-183,229
-47% -$9.61M 0.01% 946
2016
Q3 		$20.4M Buy
385,747
+132,724
+52% +$5.78M 0.02% 521
2016
Q2 		$10.6M Buy
253,023
+240,636
+1,943% +$11.9M 0.01% 808
2016
Q1 		$503K Sell
12,387
-509
-4% -$21.8K ﹤0.01% 2074
2015
Q4 		$837K Buy
12,896
+6,980
+118% +$458K ﹤0.01% 1804
2015
Q3 		$418K Buy
5,916
+4,335
+274% +$424K ﹤0.01% 2314
2015
Q2 		$176K Sell
1,581
-366,918
-100% -$39.5M ﹤0.01% 2862
2015
Q1 		$34.8M Sell
368,499
-14,120
-4% -$1.58M 0.04% 394
2014
Q4 		$42.9M Buy
382,619
+92,057
+32% +$8.22M 0.04% 365
2014
Q3 		$17.8M Buy
290,562
+142,005
+96% +$6.12M 0.02% 593
2014
Q2 		$6.81M Buy
148,557
+72,101
+94% +$2.94M 0.01% 890
2014
Q1 		$2.99M Sell
76,456
-15,341
-17% -$513K ﹤0.01% 1075
2013
Q4 		$2.2M Buy
91,797
+201
+0.2% +$4.58K ﹤0.01% 1152
2013
Q3 		$2.56M Buy
+91,596
New +$2.53M ﹤0.01% 1114

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's AGIO Position: Q4 2016 in Review

BlackRock Advisors reduced its Agios Pharmaceuticals (AGIO) stake by 47% in Q4 2016, selling an estimated $9.61M and leaving 202,518 shares worth $8.45M. The position accounts for 0.01% of the portfolio, ranked #946.

BlackRock Advisors first reported a position in AGIO in Q3 2013 and has held it in 14 quarters since. The position peaked at $42.9M in Q4 2014. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

  • BlackRock Advisors held 202,518 shares of Agios Pharmaceuticals worth $8.45M as of Q4 2016.
  • BlackRock Advisors sold 183,229 Agios Pharmaceuticals shares in Q4 2016, an estimated $9.61M.
  • Agios Pharmaceuticals made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #946 holding.
  • BlackRock Advisors first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Advisors's Agios Pharmaceuticals position peaked at $42.9M in Q4 2014.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.